Kimberly, 2004 - Google Patents
Intramembrane proteolysis and signal transduction: The γ-secretase complex and its connection to Alzheimer's diseaseKimberly, 2004
- Document ID
- 4671053687638726724
- Author
- Kimberly W
- Publication year
External Links
Snippet
The aim of this thesis is to elucidate the mechanism of γ-secretase-mediated signaling in development and disease. γ-Secretase is an unusual intramembrane-cleaving protease that first garnered attention due to its generation of the amyloid-β peptide (Aβ), which …
- 206010001897 Alzheimer's disease 0 title abstract description 52
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Buxbaum et al. | Alzheimer amyloid protein precursor in the rat hippocampus: transport and processing through the perforant path | |
| Schenk et al. | Therapeutic Approaches Related to Amyloid-. beta. Peptide and Alzheimer's Disease | |
| Sisodia et al. | Role of the β‐amyloid protein in Alzheimer's disease | |
| Selkoe | Amyloid β-protein and the genetics of Alzheimer's disease | |
| JP5053746B2 (en) | Gene sequences and proteins related to Alzheimer's disease and uses thereof | |
| US7479372B2 (en) | Beta-secretase substrates and uses thereof | |
| WO2008051326A2 (en) | Identification of contactins and l1- cams as ligands for the amyloid precursor protein | |
| Panegyres | The functions of the amyloid precursor protein gene | |
| Lefterov et al. | Human bleomycin hydrolase regulates the secretion of amyloid precursor protein | |
| Kuan et al. | PAT1a modulates intracellular transport and processing of amyloid precursor protein (APP), APLP1, and APLP2 | |
| Dowjat et al. | A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): Comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations | |
| Kimberly | Intramembrane proteolysis and signal transduction: The γ-secretase complex and its connection to Alzheimer's disease | |
| Siegel et al. | Tomoregulin‐2 is found extensively in plaques in Alzheimer's disease brain | |
| Xia et al. | Amyloid precursor protein: a practical approach | |
| US20070287666A1 (en) | Modulator of gamma-secretase | |
| Okochi et al. | Presenilin 1 cleavage is a universal event in human organs | |
| Grigorenko et al. | Molecular basis of Alzheimer’s disease | |
| JP5379119B2 (en) | Gene sequences and proteins related to Alzheimer's disease and uses thereof | |
| Gabriel | Investigating the physiological function of BACE1 and its role in metabolism | |
| Savaglio | Confirmation and Characterization of a Functional APP/GAP-43 Protein Interaction | |
| Cai | Altered production of A-beta by mutations of the amyloid protein precursor linked to familial Alzeimer's disease | |
| Lee et al. | Biology and molecular neuropathology of ẞ-amyloid protein | |
| Pannaccione et al. | Doctorate School in Molecular Medicine Doctorate Program in Neuroscience Coordinator: Prof Lucio Annunziato XXVIII Cycle | |
| Westmeyer | Identification of a BACE dimer and characterization of its biochemical and enzymatic properties | |
| Brunkan | Characterization of domains important for stabilization and maturation of the Alzheimer's disease protein presenilin-1, and their impact on presenilinase and gamma-secretase activity |